(Q53519349)

English

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

scientific article published in June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

quality of life

1 reference

based on heuristic

author name string

L Voruganti

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

L Cortese

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

L Oyewumi

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

Z Cernovsky

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

S Zirul

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

A Awad

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

Schizophrenia Research

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

43

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

2-3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

135-145

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subjective response to neuroleptics in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advances in the pharmacotherapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol-induced dysphoria in patients with Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic dysphoria

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Will the new antipsychotics improve the treatment of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications from the use of tranquilizing drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptics and the neuroleptic-induced deficit syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of antipsychotic agents. Do newer agents offer advantages?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishing cost-effectiveness of atypical neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics and dynamics of response to haloperidol in acute schizophrenia—A longitudinal study of the therapeutic process

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Which atypical antipsychotic.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical complications of new antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

'Akinetic Depression' in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Subjective response to antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Is neuroleptic dysphoria a healthy response?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The neurobiology of craving: implications for the understanding and treatment of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2899%2900154-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0920-9964(99)00154-1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10858632

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53519349&oldid=1508043943"